
On Tuesday, Senator Amy Klobuchar said her Senate antitrust panel will hold a hearing on the lack of competition in the ticketing industry after Ticketmaster’s problems last week managing the sale of Taylor Swift tickets.
“The high fees, site disruptions and cancellations that customers experienced shows how Ticketmaster’s dominant market position means the company does not face any pressure to continually innovate and improve,” Klobuchar said. “That’s why we will hold a hearing on how consolidation in the live entertainment and ticketing industry harms customers and artists alike.”
Related: DOJ Opens Antitrust Probe Into Ticketmaster
Sens. Amy Klobuchar and Mike Lee said the disastrous presale for Swift’s “The Eras Tour” highlighted problems with consolidation and the lack of incentive for Ticketmaster, which merged with Live Nation in 2010 to dominate the market, to provide better services.
Taylor Swift on Friday said it was “excruciating” for her to watch fans struggle to secure tickets and that she had been assured that Ticketmaster could handle large demand, reported Reuters. After technical issues caused long queues, freezing pages and presale delays on the site, Ticketmaster eventually canceled the public sale for the tour.
Klobuchar was one of three lawmakers who argued in a letter on Monday that Ticketmaster and owner Live Nation Entertainment, the events ticketing giant behind the recently botched sale of Taylor Swift concert tickets, should be broken up by the Department of Justice if any misconduct is found in an ongoing investigation.
“The high fees, site disruptions and cancellations that customers experienced shows how Ticketmaster’s dominant market position means the company does not face any pressure to continually innovate and improve,” she said.
Featured News
Trump Administration Steps Up Pressure On EU Digital Laws
May 18, 2025 by
CPI
Elton John Slams UK Government’s AI Copyright Plan as ‘Theft’
May 18, 2025 by
CPI
Anthropic’s Legal Team Blames AI “Hallucination” for Citation Error in Copyright Lawsuit
May 18, 2025 by
CPI
Intel Challenges €376 Million EU Antitrust Fine in Ongoing Legal Battle
May 18, 2025 by
CPI
FTC Chairman Highlights Fiscal Responsibility and Consumer Protection in House Testimony
May 18, 2025 by
CPI
Antitrust Mix by CPI
Antitrust Chronicle® – Healthcare Antitrust
May 14, 2025 by
CPI
Healthcare & Antitrust: What to Expect in the New Trump Administration
May 14, 2025 by
Nana Wilberforce, John W O'Toole & Sarah Pugh
Patent Gaming and Disparagement: Commission Fines Teva For Improperly Protecting Its Blockbuster Medicine
May 14, 2025 by
Blaž Višnar, Boris Andrejaš, Apostolos Baltzopoulos, Rieke Kaup, Laura Nistor & Gianluca Vassallo
Strategic Alliances in the Pharma Sector: An EU Competition Law Perspective
May 14, 2025 by
Christian Ritz & Benedikt Weiss
Monopsony Power in the Hospital Labor Market
May 14, 2025 by
Kevin E. Pflum & Christian Salas